Volker Knappertz, MD, as Executive Vice President, Research and Development, to lead the consolidated R&D function and to further enhance and advance the Aurinia pipelineScott Habig, as Chief Commercial Officer, to lead and enhance Aurinia’s commercial capabilities, replacing Max Colao, who led the formation of the...

Related Keywords

Rockville , Maryland , United States , United Kingdom , America , British , Robertb Huizinga , Volker Knappertz , Peter Greenleaf , Dede Sheel , Neil Solomons , Scott Habig , Max Colao , Dana Lynch , Neurology At Yale University , Ucb Inc , Sales At Human Genome Sciences , Nasdaq , Gw Pharmaceuticals , Centocor Inc , Pfizer , Heinrich Heine University , Anacor Pharmaceuticals , Global Clinical Development At Teva Pharmaceuticals , Cologne University , Stern School Of Business , Aurinia Pharmaceuticals Inc , Health Science , Myovant Sciences , Deutsche Bank , Corporate Communications , University Of Pennsylvania , Business Administration , Aurinia Pharmaceuticals , Executive Vice President , Chief Commercial Officer , Vice President , Investor Relations , British Columbia , Chief Medical Officer , Chief Executive Officer , Global Clinical Development , Teva Pharmaceuticals , Medical Degree , Yale University , Systemic Lupus Erythematosus , Human Genome Sciences , Sierra Oncology , Aimmune Therapeutics , America Securities , Red Cell Aplasia , Drug Interactions , Moderate Hepatic Impairment , Prescribing Information , Boxed Warning , Medication Guide ,